A significantly increased expression of CD206 at IT level (mean score: 0±0 for control vs 2.3±0.5 for bcl-2 overexpressing tumors, p=0.007) was observed in bcl-2 overexpressing tumor xenografts when compared with control ones (online supplementary figure S5C, S5E). This evidence concerns the gene BCL2 and neoplasm.